New York, Dec. 14, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Drug Device Combination Products Industry" - https://www.reportlinker.com/p05960612/?utm_source=GNW
3 Billion by 2027, growing at a CAGR of 5.7% over the analysis period 2020-2027. Drug Eluting Stents, one of the segments analyzed in the report, is projected to record a 5.1% CAGR and reach US$14 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Infusion Pumps segment is readjusted to a revised 5.6% CAGR for the next 7-year period.

The U.S. Market is Estimated at $24.4 Billion, While China is Forecast to Grow at 8.8% CAGR

The Drug Device Combination Products market in the U.S. is estimated at US$24.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$28.1 Billion by the year 2027 trailing a CAGR of 8.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.1% and 5.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.6% CAGR.

Photodynamic Therapy Segment to Record 5.1% CAGR

In the global Photodynamic Therapy segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2 Billion in the year 2020 will reach a projected size of US$2.8 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$17.9 Billion by the year 2027, while Latin America will expand at a 6.1% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 202-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,




Read the full report: https://www.reportlinker.com/p05960612/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Drug Device Combination Products Competitor Market Share
Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: Drug Device Combination Products Global Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 2: Drug Device Combination Products Global Retrospective
Market Scenario in US$ Million by Region/Country: 2012-2019

Table 3: Drug Device Combination Products Market Share Shift
across Key Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Drug Eluting Stents (Segment) World Market by
Region/Country in US$ Million: 2020 to 2027

Table 5: Drug Eluting Stents (Segment) Historic Market Analysis
by Region/Country in US$ Million: 2012 to 2019

Table 6: Drug Eluting Stents (Segment) Market Share Breakdown
of Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: Infusion Pumps (Segment) Potential Growth Markets
Worldwide in US$ Million: 2020 to 2027

Table 8: Infusion Pumps (Segment) Historic Market Perspective
by Region/Country in US$ Million: 2012 to 2019

Table 9: Infusion Pumps (Segment) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 10: Photodynamic Therapy (Segment) Geographic Market
Spread Worldwide in US$ Million: 2020 to 2027

Table 11: Photodynamic Therapy (Segment) Region Wise Breakdown
of Global Historic Demand in US$ Million: 2012 to 2019

Table 12: Photodynamic Therapy (Segment) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 13: Prefilled Syringes (Segment) World Market Estimates
and Forecasts by Region/Country in US$ Million: 2020 to 2027

Table 14: Prefilled Syringes (Segment) Market Historic Review
by Region/Country in US$ Million: 2012 to 2019

Table 15: Prefilled Syringes (Segment) Market Share Breakdown
by Region/Country: 2012 VS 2020 VS 2027

Table 16: Antimicrobial Wound Dressings (Segment) World Market
by Region/Country in US$ Million: 2020 to 2027

Table 17: Antimicrobial Wound Dressings (Segment) Historic
Market Analysis by Region/Country in US$ Million: 2012 to 2019

Table 18: Antimicrobial Wound Dressings (Segment) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 19: Inhalers (Segment) World Market Estimates and
Forecasts in US$ Million by Region/Country: 2020 to 2027

Table 20: Inhalers (Segment) Market Worldwide Historic Review
by Region/Country in US$ Million: 2012 to 2019

Table 21: Inhalers (Segment) Market Percentage Share
Distribution by Region/Country: 2012 VS 2020 VS 2027

Table 22: Transdermal Patches (Segment) Market Opportunity
Analysis Worldwide in US$ Million by Region/Country: 2020 to
2027

Table 23: Transdermal Patches (Segment) Global Historic Demand
in US$ Million by Region/Country: 2012 to 2019

Table 24: Transdermal Patches (Segment) Market Share
Distribution in Percentage by Region/Country: 2012 VS 2020 VS
2027

Table 25: Other Drug Device Combination Products (Segment)
World Market by Region/Country in US$ Million: 2020 to 2027

Table 26: Other Drug Device Combination Products (Segment)
Historic Market Analysis by Region/Country in US$ Million: 2012
to 2019

Table 27: Other Drug Device Combination Products (Segment)
Market Share Breakdown of Worldwide Sales by Region/Country:
2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Drug Device Combination Products Market Share (in %) by
Company: 2019 & 2025
Market Analytics
Table 28: United States Drug Device Combination Products Market
Estimates and Projections in US$ Million by Segment: 2020 to
2027

Table 29: Drug Device Combination Products Market in the United
States by Segment: A Historic Review in US$ Million for
2012-2019

Table 30: United States Drug Device Combination Products Market
Share Breakdown by Segment: 2012 VS 2020 VS 2027

CANADA
Table 31: Canadian Drug Device Combination Products Market
Estimates and Forecasts in US$ Million by Segment: 2020 to 2027

Table 32: Canadian Drug Device Combination Products Historic
Market Review by Segment in US$ Million: 2012-2019

Table 33: Drug Device Combination Products Market in Canada:
Percentage Share Breakdown of Sales by Segment for 2012, 2020,
and 2027

JAPAN
Table 34: Japanese Market for Drug Device Combination Products:
Annual Sales Estimates and Projections in US$ Million by
Segment for the Period 2020-2027

Table 35: Drug Device Combination Products Market in Japan:
Historic Sales Analysis in US$ Million by Segment for the
Period 2012-2019

Table 36: Japanese Drug Device Combination Products Market
Share Analysis by Segment: 2012 VS 2020 VS 2027

CHINA
Table 37: Chinese Drug Device Combination Products Market
Growth Prospects in US$ Million by Segment for the Period
2020-2027

Table 38: Drug Device Combination Products Historic Market
Analysis in China in US$ Million by Segment: 2012-2019

Table 39: Chinese Drug Device Combination Products Market by
Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027

EUROPE
Market Facts & Figures
European Drug Device Combination Products Market: Competitor
Market Share Scenario (in %) for 2019 & 2025
Market Analytics
Table 40: European Drug Device Combination Products Market
Demand Scenario in US$ Million by Region/Country: 2020-2027

Table 41: Drug Device Combination Products Market in Europe:
A Historic Market Perspective in US$ Million by Region/Country
for the Period 2012-2019

Table 42: European Drug Device Combination Products Market
Share Shift by Region/Country: 2012 VS 2020 VS 2027

Table 43: European Drug Device Combination Products Market
Estimates and Forecasts in US$ Million by Segment: 2020-2027

Table 44: Drug Device Combination Products Market in Europe in
US$ Million by Segment: A Historic Review for the Period
2012-2019

Table 45: European Drug Device Combination Products Market
Share Breakdown by Segment: 2012 VS 2020 VS 2027

FRANCE
Table 46: Drug Device Combination Products Market in France by
Segment: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 47: French Drug Device Combination Products Historic
Market Scenario in US$ Million by Segment: 2012-2019

Table 48: French Drug Device Combination Products Market Share
Analysis by Segment: 2012 VS 2020 VS 2027

GERMANY
Table 49: Drug Device Combination Products Market in Germany:
Recent Past, Current and Future Analysis in US$ Million by
Segment for the Period 2020-2027

Table 50: German Drug Device Combination Products Historic
Market Analysis in US$ Million by Segment: 2012-2019

Table 51: German Drug Device Combination Products Market Share
Breakdown by Segment: 2012 VS 2020 VS 2027

ITALY
Table 52: Italian Drug Device Combination Products Market
Growth Prospects in US$ Million by Segment for the Period
2020-2027

Table 53: Drug Device Combination Products Historic Market
Analysis in Italy in US$ Million by Segment: 2012-2019

Table 54: Italian Drug Device Combination Products Market by
Segment: Percentage Breakdown of Sales for 2012, 2020, and 2027

UNITED KINGDOM
Table 55: United Kingdom Market for Drug Device Combination
Products: Annual Sales Estimates and Projections in US$ Million
by Segment for the Period 2020-2027

Table 56: Drug Device Combination Products Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Segment for
the Period 2012-2019

Table 57: United Kingdom Drug Device Combination Products
Market Share Analysis by Segment: 2012 VS 2020 VS 2027

SPAIN
Table 58: Spanish Drug Device Combination Products Market
Estimates and Forecasts in US$ Million by Segment: 2020 to 2027

Table 59: Spanish Drug Device Combination Products Historic
Market Review by Segment in US$ Million: 2012-2019

Table 60: Drug Device Combination Products Market in Spain:
Percentage Share Breakdown of Sales by Segment for 2012, 2020,
and 2027

RUSSIA
Table 61: Russian Drug Device Combination Products Market
Estimates and Projections in US$ Million by Segment: 2020 to
2027

Table 62: Drug Device Combination Products Market in Russia by
Segment: A Historic Review in US$ Million for 2012-2019

Table 63: Russian Drug Device Combination Products Market Share
Breakdown by Segment: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 64: Rest of Europe Drug Device Combination Products
Market Estimates and Forecasts in US$ Million by Segment:
2020-2027

Table 65: Drug Device Combination Products Market in Rest of
Europe in US$ Million by Segment: A Historic Review for the
Period 2012-2019

Table 66: Rest of Europe Drug Device Combination Products
Market Share Breakdown by Segment: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 67: Asia-Pacific Drug Device Combination Products Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 68: Drug Device Combination Products Market in
Asia-Pacific: Historic Market Analysis in US$ Million by
Region/Country for the Period 2012-2019

Table 69: Asia-Pacific Drug Device Combination Products Market
Share Analysis by Region/Country: 2012 VS 2020 VS 2027

Table 70: Drug Device Combination Products Market in
Asia-Pacific by Segment: Estimates and Projections in US$
Million for the Period 2020-2027

Table 71: Asia-Pacific Drug Device Combination Products
Historic Market Scenario in US$ Million by Segment: 2012-2019

Table 72: Asia-Pacific Drug Device Combination Products Market
Share Analysis by Segment: 2012 VS 2020 VS 2027

AUSTRALIA
Table 73: Drug Device Combination Products Market in Australia:
Recent Past, Current and Future Analysis in US$ Million by
Segment for the Period 2020-2027

Table 74: Australian Drug Device Combination Products Historic
Market Analysis in US$ Million by Segment: 2012-2019

Table 75: Australian Drug Device Combination Products Market
Share Breakdown by Segment: 2012 VS 2020 VS 2027

INDIA
Table 76: Indian Drug Device Combination Products Market
Estimates and Forecasts in US$ Million by Segment: 2020 to 2027

Table 77: Indian Drug Device Combination Products Historic
Market Review by Segment in US$ Million: 2012-2019

Table 78: Drug Device Combination Products Market in India:
Percentage Share Breakdown of Sales by Segment for 2012, 2020,
and 2027

SOUTH KOREA
Table 79: Drug Device Combination Products Market in South
Korea: Recent Past, Current and Future Analysis in US$ Million
by Segment for the Period 2020-2027

Table 80: South Korean Drug Device Combination Products
Historic Market Analysis in US$ Million by Segment: 2012-2019

Table 81: Drug Device Combination Products Market Share
Distribution in South Korea by Segment: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 82: Rest of Asia-Pacific Market for Drug Device
Combination Products: Annual Sales Estimates and Projections in
US$ Million by Segment for the Period 2020-2027

Table 83: Drug Device Combination Products Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Segment
for the Period 2012-2019

Table 84: Rest of Asia-Pacific Drug Device Combination Products
Market Share Analysis by Segment: 2012 VS 2020 VS 2027

LATIN AMERICA
Table 85: Latin American Drug Device Combination Products
Market Trends by Region/Country in US$ Million: 2020-2027

Table 86: Drug Device Combination Products Market in Latin
America in US$ Million by Region/Country: A Historic
Perspective for the Period 2012-2019

Table 87: Latin American Drug Device Combination Products
Market Percentage Breakdown of Sales by Region/Country: 2012,
2020, and 2027

Table 88: Latin American Drug Device Combination Products
Market Growth Prospects in US$ Million by Segment for the
Period 2020-2027

Table 89: Drug Device Combination Products Historic Market
Analysis in Latin America in US$ Million by Segment: 2012-2019

Table 90: Latin American Drug Device Combination Products
Market by Segment: Percentage Breakdown of Sales for 2012,
2020, and 2027

ARGENTINA
Table 91: Argentinean Drug Device Combination Products Market
Estimates and Forecasts in US$ Million by Segment: 2020-2027

Table 92: Drug Device Combination Products Market in Argentina
in US$ Million by Segment: A Historic Review for the Period
2012-2019

Table 93: Argentinean Drug Device Combination Products Market
Share Breakdown by Segment: 2012 VS 2020 VS 2027

BRAZIL
Table 94: Drug Device Combination Products Market in Brazil by
Segment: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 95: Brazilian Drug Device Combination Products Historic
Market Scenario in US$ Million by Segment: 2012-2019

Table 96: Brazilian Drug Device Combination Products Market
Share Analysis by Segment: 2012 VS 2020 VS 2027

MEXICO
Table 97: Drug Device Combination Products Market in Mexico:
Recent Past, Current and Future Analysis in US$ Million by
Segment for the Period 2020-2027

Table 98: Mexican Drug Device Combination Products Historic
Market Analysis in US$ Million by Segment: 2012-2019

Table 99: Mexican Drug Device Combination Products Market Share
Breakdown by Segment: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 100: Rest of Latin America Drug Device Combination
Products Market Estimates and Projections in US$ Million by
Segment: 2020 to 2027

Table 101: Drug Device Combination Products Market in Rest of
Latin America by Segment: A Historic Review in US$ Million for
2012-2019

Table 102: Rest of Latin America Drug Device Combination
Products Market Share Breakdown by Segment: 2012 VS 2020 VS
2027

MIDDLE EAST
Table 103: The Middle East Drug Device Combination Products
Market Estimates and Forecasts in US$ Million by
Region/Country: 2020-2027

Table 104: Drug Device Combination Products Market in the
Middle East by Region/Country in US$ Million: 2012-2019

Table 105: The Middle East Drug Device Combination Products
Market Share Breakdown by Region/Country: 2012, 2020, and 2027

Table 106: The Middle East Drug Device Combination Products
Market Estimates and Forecasts in US$ Million by Segment: 2020
to 2027

Table 107: The Middle East Drug Device Combination Products
Historic Market by Segment in US$ Million: 2012-2019

Table 108: Drug Device Combination Products Market in the
Middle East: Percentage Share Breakdown of Sales by Segment for
2012,2020, and 2027

IRAN
Table 109: Iranian Market for Drug Device Combination Products:
Annual Sales Estimates and Projections in US$ Million by
Segment for the Period 2020-2027

Table 110: Drug Device Combination Products Market in Iran:
Historic Sales Analysis in US$ Million by Segment for the
Period 2012-2019

Table 111: Iranian Drug Device Combination Products Market
Share Analysis by Segment: 2012 VS 2020 VS 2027

ISRAEL
Table 112: Israeli Drug Device Combination Products Market
Estimates and Forecasts in US$ Million by Segment: 2020-2027

Table 113: Drug Device Combination Products Market in Israel in
US$ Million by Segment: A Historic Review for the Period
2012-2019

Table 114: Israeli Drug Device Combination Products Market
Share Breakdown by Segment: 2012 VS 2020 VS 2027

SAUDI ARABIA
Table 115: Saudi Arabian Drug Device Combination Products
Market Growth Prospects in US$ Million by Segment for the
Period 2020-2027

Table 116: Drug Device Combination Products Historic Market
Analysis in Saudi Arabia in US$ Million by Segment: 2012-2019

Table 117: Saudi Arabian Drug Device Combination Products
Market by Segment: Percentage Breakdown of Sales for 2012,
2020, and 2027

UNITED ARAB EMIRATES
Table 118: Drug Device Combination Products Market in the
United Arab Emirates: Recent Past, Current and Future Analysis
in US$ Million by Segment for the Period 2020-2027

Table 119: United Arab Emirates Drug Device Combination
Products Historic Market Analysis in US$ Million by Segment:
2012-2019

Table 120: Drug Device Combination Products Market Share
Distribution in United Arab Emirates by Segment: 2012 VS 2020
VS 2027

REST OF MIDDLE EAST
Table 121: Drug Device Combination Products Market in Rest of
Middle East: Recent Past, Current and Future Analysis in US$
Million by Segment for the Period 2020-2027

Table 122: Rest of Middle East Drug Device Combination Products
Historic Market Analysis in US$ Million by Segment: 2012-2019

Table 123: Rest of Middle East Drug Device Combination Products
Market Share Breakdown by Segment: 2012 VS 2020 VS 2027

AFRICA
Table 124: African Drug Device Combination Products Market
Estimates and Projections in US$ Million by Segment: 2020 to
2027

Table 125: Drug Device Combination Products Market in Africa by
Segment: A Historic Review in US$ Million for 2012-2019

Table 126: African Drug Device Combination Products Market
Share Breakdown by Segment: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 46
Read the full report: https://www.reportlinker.com/p05960612/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001